Generating Gene-Edited CD34⁺ Cells From Urine‑Derived iPSCs
In this webinar, Dr. Julia Peterson discusses strategies for generating gene-edited CD34⁺ cells from iPSCs using a non-integrating, stably maintained DNA vector system.
Publish Date:
June 27, 2023
Request Pricing
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
By submitting this form, you are providing your consent to STEMCELL Technologies Canada Inc. and its subsidiaries and affiliates (“STEMCELL”) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.
Related Multimedia
-
Optimizing CD34+ Cell Genome Editing for Efficiency and HSPC Maintenance
Publish Date: May 30, 2022 -
Serum- and Feeder-Free Differentiation of Erythroid Progenitor Cells from hPSCs
Publish Date: May 21, 2021
Explore Our Products
-
For differentiation of human ES or iPS cells into hematopoietic progenitor cells -
cGMP, stabilized feeder-free maintenance medium for human ES and iPS cells -
Serum-free medium for culture and expansion of hematopoietic cells -
Serum-free methylcellulose-based medium with recombinant cytokines for human ES and iPS cell-derived cells
